Home › NDC Lookup › RxCUI directory › RxCUI 1366571

34 ML raxibacumab 50 MG/ML Injection — RxCUI 1366571

RxNorm drug concept · Semantic clinical drug
RxCUI 1366571 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1366571
Official name34 ML raxibacumab 50 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asraxibacumab 1700 MG per 34 ML Injection; raxibacumab 1700 MG in 34 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Raxibacumab: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats inhalational anthrax, which is anthrax from breathing in the bacteria, and is always used with antibacterial drugs. It can also be used to prevent inhalational anthrax wh...
  • It is given once as an IV infusion that takes a little over two hours. You'll get diphenhydramine beforehand to lower the chance of a reaction. Your care team handles all of it.
  • Some people get rash, itching, arm or leg pain, sleepiness, headache or soreness and redness where the needle goes in. These were the most commonly reported effects in healthy volu...
  • A serious allergic reaction is the main risk. Tell your nurse right away if you have hives, chest or throat tightness, lip or throat swelling, trouble breathing or feel faint. You'...
📖 Read our full Raxibacumab guide →

🕸️ Concept Web — How 34 ML raxibacumab 50 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 34 ML raxibacumab 50 MG/ML Injection RxCUI 1366571

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Raxibacumab 1366567
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Raxibacumab Injection 1724255
    • Raxibacumab Injectable Product 1366569
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Raxibacumab 50 MG/ML 1366568

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Raxibacumab 50 MG/ML SCDC · 1366568
  • Raxibacumab Injection SCDF · 1724255
  • Raxibacumab Injectable Product SCDG · 1366569

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1366571 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71655-0103-01 1 VIAL, SINGLE-USE in 1 CARTON (71655-103-01) / 34 mL in 1... Raxibacumab Emergent Manufacturing Operations Baltimore LLC 2012-12-14
Observed labelers: Emergent Manufacturing Operations Baltimore LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.